Latest ArticlesExosomes are nanovesicles secreted by cells. As a natural drug carrier, exosomes have attracted extensive attention from researchers. Exosomes show good biocompatibility, low immunogenicity, targeting, and long-circulating, but low drug-loading capacity. Hybridizing exosomes with synthetic nanocarriers to construct hybrid exosome vesicles can not only retain the original advantages of exosomes but also improve the drug-loading capacity and obtain new biological functions. This review comprehensively summarizes the different types of exosomes and nanocarriers used in the construction of hybrid exosome vesicles, concludes the related preparation methods, and discusses the advantages of the hybrid exosome vesicles as nanoscale drug delivery systems and their critical common problems that need to be solved.
Intravesical instillation is of great significance to prevent tumor recurrence after bladder cancer surgery. Therefore, developing sustained-release preparations for perfusion delivery and highly effective drug combinations plays an important role in improving the efficacy, shortening the administration period and enhancing the patient compliance. In this review, drugs(traditional antineoplastics, monoclonal antibodies, nucleic acid drugs, etc.) for bladder perfusion and novel drug delivery systems(liposomes, micelles, nanoparticles, hydrogels, etc.) for perfusion delivery used in the treatment of bladder cancer in recent years are summarized in order to provide new approaches for intravesical drug delivery.
Drug-device combination products have become a hot spot of innovation with the rapid development of modern science and technology. Drug-device combined products integrate the functions of medicines and medical devices, so they generally have the characteristics of high risk and complex technical performance. The development of drug-device combination products in China is still in its infancy and the regulatory system needs to be gradually improved. The guidances issued by U.S. FDA describe the key role of human factors engineering in the development of drug-device combination products, as well as the importance of human factors engineering to product safety and effectiveness. The relatively mature review thinkings of U.S. FDA might have a positive role in promoting the understanding of human factors engineering and evaluation of some related indicators for drug-device combination products of regulatory authorities in China.
Owing to simple preparation process, high drug loading capacity and strong adhesion, nanocrystals can effectively solve the problems of short-term retention time, slow release rate and low bioavailability of poorly water-soluble drugs. Therefore, it has become a hot research topic in pharmaceutics in recent years. In this paper, the preparation technologies of nanocrystals and their research progress of applications in mucosal drug delivery systems such as nasal, ocular, oral, skin and pulmonary delivery systems are reviewed, hoping to provide a reference basis for the development of nanocrystal-based dosage forms of poorly soluble drugs.
Baicalein, a flavone derived from Scutellaria baicalensis, exhibits antitumor effect by suppressing tumor cell proliferation, inducing tumor cell apoptosis, inhibiting tumor angiogenesis, and regulating the tumor microenvironment. However, its poor solubility has attenuated the bioavailability and thus restricting the efficacy. Many studies utilize nano-drug delivery systems to improve bioavailability and antitumor efficacy of baicalein. This review summarizes the recent studies concerning the antitumor mechanisms of baicalein and its nano delivery systems to provide approaches for its further basic research and clinical application.
Continuous flow process for the synthesis of losartan(1) was realized by microchannel reactor technology based on the synthetic routes reported in the literature. Compound 1 was obtained with an overall yield of 70.3%[based on 2-cyano-4'-methylbiphenyl(2)] via bromination, N-alkylation and tetrazolium cycloaddition reaction using 2 and 2-butyl-4-chloro-1H-imidazole-5-carboxaldehyde(3) as the starting materials. The optimized process bearing mild reaction conditions, simple operation and higher security is suitable for industrial production.
An improved synthetic process of roxadustat(1) was reported. Methyl 4-hydroxy-7-phenoxyisoquinoline-3-carboxylate(2) was chlorinated by 1,3-dichloro-5,5-dimethylhydantoin to obtain methyl 1-chloro-4-hydroxy-7-phenoxyisoquinoline-3-carboxylate(3), 3 was transformed into 1-methyl-4-hydroxy-7-phenoxyisoquinoline-3-carboxylic acid(4) through coupling reaction with methylboronic acid and hydrolysis. Then 4 was amidated with glycine methyl ester hydrochloride to generate methyl (1-methyl-4-hydroxy-7-phenoxyisoquinoline-3-carbonyl)-glycinate(5). Finally, the target compound 1 was obtained from 5 by hydrolysis reaction with a purity of 99.9% and an overall yield of 60.8%(based on 2). The optimized process was easy to operate and had been verified by pilot test, which was suitable for industrial production.
In order to control the quality of varenicline tartrate, four related substances, namely 7,8,9,10-tetrahydro-6,10-methano-6H-pyrazino[2,3-h][3]benzazepine-1-oxide(related substance A), 7,8,9,10-tetrahydro-6,10-methano-6H-pyrazino[2,3-h][3]benzazepine-1,4-dioxide(related substance B), 1,5,6,7,8,9-hexahydro-5,9-methanoimidazo[4,5-h][3]benzazepine(related substance C) and 7,8,9,10-tetrahydro-8-nitroso-6,10-methano-6H-pyrazino[2,3-h][3]benzazepine(related substance D), were synthesized based on the synthetic process of varenicline tartrate. The structures of these related substances were confirmed by HRMS, 1H NMR and 13C NMR.
Using adipic acid dihydrazide(ADH) as a linkage, the polymer hyaluronic acid(HA)-ADH-artesunate(1) was synthesized. Then, the polymeric micelles of HA-ADH-1 were prepared by ultrasonic dispersion. Their characteristics in vitro and anti-inflammatory effects in vitro and in vivo were investigated. The observation of transmission electron microscopy revealed that the HA-ADH-1 micelles was spherical, and the results of dynamic light scattering showed that the average particle size of HA-ADH-1 micelles was 170.90 nm. The cumulative release at 48 h of 1 from HA-ADH-1 micelles in the physiological environment(pH 7.4) was less than 50%, which was much lower than that of free 1, indicating that HA-ADH-1 micelles had sustained-release property and stable structure. The cytotoxicity and uptake assay results showed that HA-ADH-1 micelles could bind to CD44 receptors highly expressed on the macrophage surface, showing specific targeting to inflammatory macrophages induced by lipopolysaccharide, then enhanced the intracellular accumulation of 1. Therefore, the micelles demonstrated a better killing effect on inflammatory macrophages.
Ciclopirox olamine(1) microsponges were prepared by quasi emulsion solvent diffusion method. The effects of mass ratio of polymer(ethyl cellulose) to 1, polyvinyl alcohol concentration and stirring speed on the encapsulation rate and yield of 1 microsponges were investigated with single factor test and Box-Behnken design combined with response surface methodology. The optimal formulation and process parameters were as follows: the mass ratio of ethyl cellulose to 1 was 2.40∶1, the concentration of polyvinyl alcohol was 2.68%, and the stirring speed was 350 r/min. The optimized microsponges had a porous spherical structure with uniform particle size distribution, the volume mean diameter and surface mean diameter were (67.60±0.47) and (57.03±0.80)μm, respectively. In saline containing 30% polyethylene glycol 400, the cumulative release rate at 8 h of the bulk drug reached (74.85±0.60)%, while the cumulative release rate at 48 h of 1 microsponges was (72.81±1.08)%, indicating that the microsponges had a certain sustained-release effect.